Evaluation of Cumulative Meta-analysis of Rare Events as a Tool for Clinical Trials Safety Monitoring.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 32886118.
- Also identified by DOI 10.1001/jamanetworkopen.2020.15031 and PMC identifier 7489838.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This meta-analysis evaluates the use of cumulative meta-analysis of rare events as a tool for safety monitoring of clinical trials using the example of coronary bioresorbable vascular scaffold–associated thrombosis.
Medical subject headings
- Bias
- Randomized Controlled Trials as Topic
- Risk Assessment
- Safety Management